News | April 16, 2024
Cipla Health strengthens its play in beauty and personal care
CHL is strengthening its play in the fast-growing beauty and personal care sector
CHL is strengthening its play in the fast-growing beauty and personal care sector
The demand in Africa for COVID-19 vaccines has declined
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
Fluid bed processes: drying, granulating, and coating in just one product container
A game changing solution for the pharmaceutical industry
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Subscribe To Our Newsletter & Stay Updated
